ROM InWest Invests 5 Million Euros in Confocal.nl for Live-Cell Microscopy Innovation
Amsterdam, Tuesday, 24 December 2024.
ROM InWest and Nascent Ventures invest in Confocal.nl to enhance live-cell microscopy, supporting biotech advancements and wider accessibility for scientific research.
Advancing Healthcare Technology
This significant investment represents a major advancement in healthtech, specifically in the field of microscopy research. Confocal.nl, based in Amsterdam, has developed sophisticated microscopes that enable scientists to study living cells more efficiently by utilizing minimal laser light while maintaining high resolution [1]. The technology prevents cells from altering their behavior, bleaching, or dying prematurely, allowing for longer and more accurate studies of cellular processes [1].
Expanding Access to Critical Research Tools
According to Pim Vos, CEO of Confocal.nl, their innovation makes complex confocal microscopy more accessible and suitable for a broader scientific community [1]. This accessibility is particularly crucial for research into new medications and treatments for complex diseases [1]. The global market for confocal microscopes is currently valued at US$ 1.3 billion in 2024 and is projected to reach US$ 1.8 billion by 2034 [5].
Strategic Growth and International Expansion
The €5 million investment will be utilized for product automation and increasing international visibility [1]. Confocal.nl aims to expand its reach in both scientific and industrial research sectors, with a particular focus on European and United States markets [1]. The company joins forces with several strategic partners, including the Rabobank Startup & Scale-up team, RVO Innovatiekrediet, VCC TechNanoFund, ECFG, University of Amsterdam Ventures, and Innovatiefonds Noord-Holland [1].
Impact on Medical Research
Janet Nieboer, CEO of ROM InWest, emphasizes that live cell imaging technology shows particular promise in the fight against diseases such as cancer [1]. The technology’s broader accessibility is expected to contribute to both more effective treatment methods and reduced healthcare costs [1]. This advancement continues the Netherlands’ rich history in microscopy innovation, building upon the foundation laid by pioneers in the field [2].